Evidence map›Paper›PMID 33912379›Full record

ArticleNanotheranostics2021

Therapeutic Efficacy of Lactonic Sophorolipids: Nanoceria-Assisted Combination Therapy of NSCLC using HDAC and Hsp90 Inhibitors.

Shuguftha Naz, Tuhina Banerjee, Filbert Totsingan, Kalee Woody, Richard A Gross, Santimukul Santra

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanotheranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Application of Biosurfactants in Medical Sciences.Molecules (Basel, Switzerland) · 2024
    Review
  5. Nanoceria: an innovative strategy for cancer treatment.Cellular and molecular life sciences : CMLS · 2023
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shuguftha NazDepartment of Chemistry, Pittsburg State University, Pittsburg, Kansas 66762, United States.
Tuhina BanerjeeDepartment of Chemistry, Pittsburg State University, Pittsburg, Kansas 66762, United States.
Filbert TotsinganDepartment of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, New York 12180, United States.
Kalee WoodyDepartment of Chemistry, Pittsburg State University, Pittsburg, Kansas 66762, United States.
Richard A GrossDepartment of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, New York 12180, United States.
Santimukul SantraDepartment of Chemistry, Pittsburg State University, Pittsburg, Kansas 66762, United States.
Pittsburg State University · USRensselaer Polytechnic Institute · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Douglas E Wright · 2012 to 2026
$63.0M
NIGMS NIH HHS P20 GM103418
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CeriumGlycolipidsHistone Deacetylase InhibitorsA549 CellsAnimalsAntineoplastic AgentsAntioxidantsCarcinoma, Non-Small-Cell LungCHO CellsCombined Modality TherapyCricetinaeCricetulusHSP90 Heat-Shock ProteinsHumansLung NeoplasmsTriazoles16-(2'-O-glucopyranosylglucopyranosyloxy)hexadecanoic acid 1',4''-lactone 6',6''-diacetateAntineoplastic AgentsAntioxidantsceric oxideCeriumGlycolipidsHistone Deacetylase InhibitorsHSP90 Heat-Shock ProteinsSTA 9090Triazolesantioxidant nanoceriacancer therapyganetespibHDAC inhibitionlactonic sophorolipid

Identifiers

PMID33912379
PMCPMC8077971
OpenAlexW3159693434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.